全文获取类型
收费全文 | 4328篇 |
免费 | 273篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 97篇 |
儿科学 | 132篇 |
妇产科学 | 52篇 |
基础医学 | 779篇 |
口腔科学 | 54篇 |
临床医学 | 324篇 |
内科学 | 913篇 |
皮肤病学 | 67篇 |
神经病学 | 371篇 |
特种医学 | 180篇 |
外科学 | 599篇 |
综合类 | 14篇 |
一般理论 | 3篇 |
预防医学 | 383篇 |
眼科学 | 60篇 |
药学 | 281篇 |
中国医学 | 3篇 |
肿瘤学 | 302篇 |
出版年
2023年 | 26篇 |
2022年 | 45篇 |
2021年 | 77篇 |
2020年 | 65篇 |
2019年 | 86篇 |
2018年 | 102篇 |
2017年 | 83篇 |
2016年 | 85篇 |
2015年 | 109篇 |
2014年 | 130篇 |
2013年 | 186篇 |
2012年 | 283篇 |
2011年 | 270篇 |
2010年 | 166篇 |
2009年 | 181篇 |
2008年 | 275篇 |
2007年 | 297篇 |
2006年 | 229篇 |
2005年 | 265篇 |
2004年 | 227篇 |
2003年 | 231篇 |
2002年 | 215篇 |
2001年 | 81篇 |
2000年 | 68篇 |
1999年 | 75篇 |
1998年 | 59篇 |
1997年 | 48篇 |
1996年 | 43篇 |
1995年 | 47篇 |
1994年 | 27篇 |
1993年 | 27篇 |
1992年 | 23篇 |
1991年 | 27篇 |
1990年 | 30篇 |
1989年 | 18篇 |
1988年 | 17篇 |
1986年 | 23篇 |
1985年 | 23篇 |
1984年 | 20篇 |
1982年 | 17篇 |
1981年 | 22篇 |
1980年 | 25篇 |
1979年 | 17篇 |
1978年 | 21篇 |
1977年 | 18篇 |
1976年 | 16篇 |
1975年 | 21篇 |
1974年 | 23篇 |
1972年 | 20篇 |
1969年 | 18篇 |
排序方式: 共有4614条查询结果,搜索用时 31 毫秒
1.
2.
Medicine, Health Care and Philosophy - 相似文献
3.
Dr. Michael Gosland Pharm.D. Dr. Bert Lum Pharm.D. Dr. Julia Schimmelpfennig Pharm.D. Dr. James Baker Pharm.D. Dr Michael Doukas M.D. 《Pharmacotherapy》1996,16(1):16-39
Cisplatin in combination with other cytotoxic agents is the backbone for a potential cure of testicular germ cell neoplasms and is a critical factor in the substantial activity observed in the treatment of small cell lung cancer, bladder cancer, and ovarian germ cell tumors. Resistance to cisplatin at the onset of treatment or at relapse limits its curative potential, however. Laboratory studies using both cells selected for cisplatin resistance by exposure to sublethal concentrations and biopsy specimens from patients' tumors provide insights for the potential mechanisms of resistance. The mechanisms identified in vitro include a complex and wide array of related and unrelated pathways such as alterations in cellular drug transport, enhanced DNA repair dependent and independent of signal transduction pathways, and enhanced intracellular detoxification such as glutathione and metallothionein systems. Studies of these mechanisms have identified a number of agents with known potential for administration to humans and that reverse cisplatin resistance in vitro; for example, reversal of cellular accumulation defects by dipyridamole; inhibition of DNA repair by hydroxyurea, pentoxifylline, and novobiocin; inhibition of the glutathione system by ethacrynic acid and buthionine sulfoximine; and inhibition of signal transduction pathways by cyclosporine, tamoxifen, and calcium channel-blocking agents. Current phase I clinical trials are focusing on the most effective doses and schedules to administer these agents in combination with cisplatin. Initial uncontrolled trials in limited numbers of patients suggest that the addition of modulators of cisplatin has the potential to reverse resistance in patients previously failing therapy. Another promising avenue for circumventing cisplatin resistance is the development of noncross-resistant platinum analogs. 相似文献
4.
5.
Susan W. Muir Katherine Berg Bert Chesworth Neil Klar Mark Speechley 《Journal of clinical epidemiology》2010,63(4):389-406
ObjectivesTo evaluate and summarize the evidence linking balance impairment as a risk factor for falls in community-dwelling older adults.Study Design and SettingSystematic review and meta-analysis. English language articles in MEDLINE, EMBASE, CINAHL (1988–2009), under keywords of accidental falls, aged, risk factors, and hip, radius, ulna, and humerus fractures; and bibliographies of retrieved articles. Community-dwelling older adults in a prospective study, at least 1-year duration, age more than 60 years, and samples not specific to a single disease-defined population were included. Sample size, inclusion/exclusion criteria, demographics, clinical balance measurement scale, type of fall outcome, method of fall ascertainment, length of follow-up, and odds ratio (OR) or risk ratio (RR) were extracted. Studies must have reported adjustment for confounders. Random effects meta-analysis to generate summary risk estimate was used. A priori evaluation of sources of heterogeneity was performed.ResultsTwenty-three studies met the selection criteria. A single summary measure could not be calculated because of the nonequivalence of the OR and RR, producing an overall fall risk of RR of 1.42 (1.08, 1.85) and OR of 1.98 (1.60, 2.46).ConclusionsBalance impairment imparts a moderate increase on fall risk in community-dwelling older adults. The type of fall outcome, the length of follow-up, and the balance measurement tool impact the magnitude of the association. Specific balance measurement scales were identified with associations for an increased fall risk, but further research is required to refine recommendations for their use in clinical practice. 相似文献
6.
F.-P. Tillmann M. Jäger D. Blondin D. Schooldermann A. Voiculescu C. Sucker B. Grabensee R. Krauspe G. R. Hetzel 《American journal of transplantation》2007,7(3):667-671
The purpose of this study was to investigate the application of intravenous iloprost as a novel therapy for the treatment of post-transplant distal limb syndrome (PTDLS). PTDLS is a benign but disabling complication in the first year after renal transplantation. It is characterized by bilateral, often incapacitating pain in the feet and or knees on motion and a significant rise in alkaline phosphatase levels on laboratory evaluation. On MRI, bone marrow edema of the affected bone regions can be demonstrated. PTDLS differs from steroid induced osteonecrosis of the hip in terms of localization, an average cumulative steroid dosage within expected limits, and a benign outcome, as PTDLS does not progress to overt cell necrosis. From August 2003 to April 2005 we treated 10 patients with MRI-proven diagnosis of PTDLS following a standardized regimen of intravenous iloprost over 5 days. Iloprost led to prompt pain relief measured on a visual analogous scale (VAS) ranging from 1 to 10 (5.6 +/- 1.5 before vs. 2.1 +/- 1.3 after treatment, p = 0.0004). PTDLS represents a benign but disabling complication following renal transplantation. Intravenous iloprost might be a promising therapeutic concept leading to a quick relief of symptoms without relevant side effects. 相似文献
7.
8.
Willem G de Voogt Ben F M Vonk Bert A Albers Florian Hintringer 《Europace : European pacing, arrhythmias, and cardiac electrophysiology》2004,6(6):561-569
Automatic capture detection systems are currently available in several cardiac pacing devices. All current systems use low-polarization electrodes and no beat to beat detection system is available for all types of electrodes. In addition the success ratio for currently available systems is not always 100%. Failure to detect capture reliably is often related to the behaviour of the electrode-tissue interface under different circumstances. Pacemaker electrodes can be considered electrochemical cells with complicated characteristics depending on time, temperature and electrical charge. This electrochemical cell is disturbed when a charge is transferred across the electrode-tissue interface during pacing. Several measures can be taken in order to minimise this disturbance or pace polarization artefact (PPA) including the use of high active surface area electrodes and application of tri-phasic pacing pulses. Another factor influencing detection of evoked potentials is the input circuit of the pacemaker affecting the PPA and the evoked response. Positive PPAs can be falsely interpreted as evoked potentials due to the undershoot of the second order filters applied in modern cardiac pacemakers. This paper explains the behaviour of the interface between the electrode and the cardiac tissue in combination with the pacemaker output circuits and input amplifiers under different circumstances. 相似文献
9.
10.